Tzu-Wen Lien Selected Research

BPR1K653

1/2011

BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tzu-Wen Lien Research Topics

Disease

4	Neoplasms (Cancer) 01/2023 - 01/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 06/2008
1	Stomach Neoplasms (Stomach Cancer) 02/2012
1	Carcinogenesis 01/2011
1	Lung Neoplasms (Lung Cancer) 07/2010
1	Virus Diseases (Viral Diseases) 01/2006
1	Migraine Disorders (Migraine) 01/2006
1	Fever (Fevers) 01/2006
1	Infections 10/2005

Drug/Important Bio-Agent (IBA)

3	ErbB Receptors (EGF Receptor)IBA 11/2019 - 06/2008
1	ImidazolesIBA 02/2012
1	Colchicine FDA LinkGeneric 02/2012
1	TubulinIBA 02/2012
1	imidazoleIBA 02/2012
1	Gefitinib (Iressa)FDA Link 06/2011
1	Transcription Factors (Transcription Factor)IBA 06/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	BPR1K653IBA 01/2011
1	Aurora KinasesIBA 01/2011
1	Phosphotransferases (Kinase)IBA 07/2010
1	parthenolideIBA 01/2006
1	Subgenomic RNAIBA 01/2006
1	Ribavirin (Virazole)FDA LinkGeneric 10/2005

Therapy/Procedure

5	Therapeutics 11/2019 - 10/2005
1	Oral Administration 01/2023
1	Precision Medicine 11/2019